BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 17767420)

  • 21. Selective stimulation of Hsp27 and alphaB-crystallin but not Hsp70 expression by p38 MAP kinase activation.
    Kato K; Ito H; Kamei K; Iwamoto I
    Cell Stress Chaperones; 1999 Jun; 4(2):94-101. PubMed ID: 10547059
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immediate-early gene induction by the stresses anisomycin and arsenite in human osteosarcoma cells involves MAPK cascade signaling to Elk-1, CREB and SRF.
    Bébien M; Salinas S; Becamel C; Richard V; Linares L; Hipskind RA
    Oncogene; 2003 Mar; 22(12):1836-47. PubMed ID: 12660819
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activation of extracellular signal-regulated kinase and c-Jun-NH(2)-terminal kinase but not p38 mitogen-activated protein kinases is required for RRR-alpha-tocopheryl succinate-induced apoptosis of human breast cancer cells.
    Yu W; Liao QY; Hantash FM; Sanders BG; Kline K
    Cancer Res; 2001 Sep; 61(17):6569-76. PubMed ID: 11522656
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MAP kinases p38 and JNK are activated by the steroid hormone 1alpha,25(OH)2-vitamin D3 in the C2C12 muscle cell line.
    Buitrago CG; Ronda AC; de Boland AR; Boland R
    J Cell Biochem; 2006 Mar; 97(4):698-708. PubMed ID: 16215981
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PKD, PKD2, and p38 MAPK mediate Hsp27 serine-82 phosphorylation induced by neurotensin in pancreatic cancer PANC-1 cells.
    Yuan J; Rozengurt E
    J Cell Biochem; 2008 Feb; 103(2):648-62. PubMed ID: 17570131
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The kinases MSK1 and MSK2 act as negative regulators of Toll-like receptor signaling.
    Ananieva O; Darragh J; Johansen C; Carr JM; McIlrath J; Park JM; Wingate A; Monk CE; Toth R; Santos SG; Iversen L; Arthur JS
    Nat Immunol; 2008 Sep; 9(9):1028-36. PubMed ID: 18690222
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phosphorylation of HSP27 and synthesis of 14-3-3epsilon are parallel responses to hyperosmotic stress in the hippocampus.
    Niswander JM; Dokas LA
    Brain Res; 2006 Oct; 1116(1):19-30. PubMed ID: 16950235
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activation of p38 mitogen-activated protein kinase abolishes insulin-mediated myocardial protection against ischemia-reperfusion injury.
    Chai W; Wu Y; Li G; Cao W; Yang Z; Liu Z
    Am J Physiol Endocrinol Metab; 2008 Jan; 294(1):E183-9. PubMed ID: 18003719
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nuclear export inhibitors and kinase inhibitors identified using a MAPK-activated protein kinase 2 redistribution screen.
    Almholt DL; Loechel F; Nielsen SJ; Krog-Jensen C; Terry R; Bjørn SP; Pedersen HC; Praestegaard M; Møller S; Heide M; Pagliaro L; Mason AJ; Butcher S; Dahl SW
    Assay Drug Dev Technol; 2004 Feb; 2(1):7-20. PubMed ID: 15090206
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epigenetic Activation of
    Wagley Y; Law PY; Wei LN; Loh HH
    Mol Pharmacol; 2017 Apr; 91(4):357-372. PubMed ID: 28153853
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of novel phosphorylation sites in MSK1 by precursor ion scanning MS.
    McCoy CE; macdonald A; Morrice NA; Campbell DG; Deak M; Toth R; McIlrath J; Arthur JS
    Biochem J; 2007 Mar; 402(3):491-501. PubMed ID: 17117922
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential p38 mitogen-activated protein kinase target phosphorylation in responders and nonresponders to infliximab.
    Waetzig GH; Rosenstiel P; Nikolaus S; Seegert D; Schreiber S
    Gastroenterology; 2003 Aug; 125(2):633-4; author reply 635-6. PubMed ID: 12891581
    [No Abstract]   [Full Text] [Related]  

  • 33. Glucocorticoids and mitogen- and stress-activated protein kinase 1 inhibitors: possible partners in the combat against inflammation.
    Beck IM; Vanden Berghe W; Gerlo S; Bougarne N; Vermeulen L; De Bosscher K; Haegeman G
    Biochem Pharmacol; 2009 Apr; 77(7):1194-205. PubMed ID: 19150610
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ELISA-PLA: A novel hybrid platform for the rapid, highly sensitive and specific quantification of proteins and post-translational modifications.
    Tong QH; Tao T; Xie LQ; Lu HJ
    Biosens Bioelectron; 2016 Jun; 80():385-391. PubMed ID: 26866564
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neutral sphingomyelinase 2 (nSMase2) is a phosphoprotein regulated by calcineurin (PP2B).
    Filosto S; Fry W; Knowlton AA; Goldkorn T
    J Biol Chem; 2010 Apr; 285(14):10213-22. PubMed ID: 20106976
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Emerging Roles of the Mitogen and Stress Activated Kinases MSK1 and MSK2.
    Reyskens KM; Arthur JS
    Front Cell Dev Biol; 2016; 4():56. PubMed ID: 27376065
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MSK1 promotes cell proliferation and metastasis in uveal melanoma by phosphorylating CREB.
    Li J; Liu X; Wang W; Li C; Li X
    Arch Med Sci; 2020; 16(5):1176-1188. PubMed ID: 32864007
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development and validation of a single-well cell-based assay for the detection of endogenous phosphoproteins.
    Sheehan AJ; Goodrich W; Banks P; Crouch MF; Osmond RI
    Assay Drug Dev Technol; 2013 Mar; 11(2):108-16. PubMed ID: 23062078
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The mammalian mitogen activated protein kinase network.
    Lenormand P
    Clin Mol Pathol; 1995 Dec; 48(6):M292-301. PubMed ID: 16696026
    [No Abstract]   [Full Text] [Related]  

  • 40. Ocular Toxicity of Mitogen-Activated Protein Kinase Inhibitors.
    Purbrick RMJ; Osunkunle OA; Talbot DC; Downes SM
    JAMA Oncol; 2017 Feb; 3(2):275-277. PubMed ID: 27892980
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.